The Muscular Dystrophy Association (MDA) brought its Engage Community Seminar to Hershey, Pennsylvania, on July 18, uniting ...

While the findings align with previous research linking smoking to ALS, researchers found no consistent evidence that heavier ...

An AI-powered brain implant helped an ALS patient regain speech by decoding brain signals. This neuroprosthesis translates ...

RAG-17 is an experimental RNA-targeting therapy designed to lower toxic SOD1 protein in people with SOD1-ALS. A six-person trial found RAG-17 was well tolerated, with no serious side effects. RAG-17 ...

Over the last five years, Canadian ALS clinics have shifted from offering genetic testing mainly to people with a family ...

A PBS documentary, "Loving John," explores a gay American Samoan man's final years with ALS. It highlights the disease's ...

Although I continue to rely on a rollator to help me walk inside the house and a mobility scooter when I’m out and about, getting the power wheelchair was a strategic, planning-ahead decision. I live ...

Study examines Qalsody safety after approval “This study is the first to systematically conduct a post-marketing [safety] ...

A self-balancing robotic exoskeleton was found safe and feasible for ALS patients with gait impairment. It helps patients practice walking hands-free, improving mobility, posture, and well-being.

Preventing TDP-43 from forming toxic clumps is widely seen as a promising strategy for developing new ALS treatments. But it’s been difficult for scientists to find a way to prevent these clumps ...